Hikma's Advair Generic Gets Further Delayed Post author:Sam Post published:March 11, 2018 Post category:BioPharma Hikma Pharmaceuticals generic version of Advair has hit a stumbling block with the FDA. Source: BioSpace You Might Also Like Taro Provides Results For December 31, 2016 February 9, 2017 SpinalCyte, LLC Receives New Japanese Patent July 20, 2017 Medpace Reports Fourth Quarter And Full Year 2016 Results February 27, 2017
